Avinger, Inc., a commercial-stage medical device company, designs, manufactures, and sells image-guided and catheter-based systems used by physicians to treat patients with peripheral arterial disease (PAD) in the United States and Europe. It develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures. The company's lumivascular products comprise Lightbox imaging consoles, as well as the Ocelot family of catheters, which are designed to penetrate a total blockage in an artery; and Pantheris, an image-guided atherectomy device that allows physicians to precisely remove arterial plaque in PAD patients. In addition, its first-generation chronic total occlusion (CTO)-crossing catheters, Wildcat, and Kittycat 2, which employs a proprietary design that uses a rotational spinning technique allowing the physician to switch between passive and active modes when navigating across a CTO. The company sells and markets its products to interventional cardiologists, vascular surgeons, and interventional radiologists. Avinger, Inc. was founded in 2007 and is headquartered in Redwood City, California.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:AVGR
CUSIPN/A
Phone650-241-7900
Debt
Debt-to-Equity RatioN/A
Current Ratio1.75
Quick Ratio1.42
Price-To-Earnings
Trailing P/E Ratio-0.02
Forward P/E Ratio-0.22
P/E GrowthN/A
Sales & Book Value
Annual Sales$9.93 million
Price / Sales0.80
Cash FlowN/A
Price / CashN/A
Book Value($42.82) per share
Price / Book-0.03
Profitability
EPS (Most Recent Fiscal Year)($70.07)
Net Income$-48,730,000.00
Net Margins-529.24%
Return on EquityN/A
Return on Assets-187.84%
Miscellaneous
Employees65
Outstanding Shares5,560,000
Market Cap$7.68
Avinger (NASDAQ:AVGR) Frequently Asked Questions
What is Avinger's stock symbol?
Avinger trades on the NASDAQ under the ticker symbol "AVGR."
When did Avinger's stock split? How did Avinger's stock split work?
Avinger shares reverse split before market open on Wednesday, January 31st 2018. The 1-40 reverse split was announced on Tuesday, January 30th 2018. The number of shares owned by shareholders was adjusted after the market closes on Tuesday, January 30th 2018. An investor that had 100 shares of Avinger stock prior to the reverse split would have 3 shares after the split.
How were Avinger's earnings last quarter?
Avinger Inc (NASDAQ:AVGR) issued its earnings results on Monday, May, 14th. The medical device company reported ($5.37) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.84) by $4.53. The medical device company had revenue of $1.81 million for the quarter. View Avinger's Earnings History.
What is the consensus analysts' recommendation for Avinger?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avinger in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
Are investors shorting Avinger?
Avinger saw a decline in short interest in June. As of June 15th, there was short interest totalling 714,090 shares, a decline of 49.4% from the May 31st total of 1,412,553 shares. Based on an average daily trading volume, of 680,310 shares, the days-to-cover ratio is currently 1.0 days. Currently, 12.9% of the company's stock are short sold. View Avinger's Current Options Chain.
Who are some of Avinger's key competitors?
Some companies that are related to Avinger include Pro-Dex (PDEX), Interpace Diagnostics Group (IDXG), AIT Therapeutics (AITB), PAVmed (PAVM), DarioHealth (DRIO), Biostage (BSTG), Cytocore common stock (MDIT), STRATA Skin Sciences (SSKN), Alliqua Biomedical (ALQA), Neurometrix (NURO), United American Healthcare (UAHC), Regenicin (RGIN), Atossa Genetics (ATOS), Viatar CTC Solutions (VRTT) and Cytori Therapeutics (CYTX).
Who are Avinger's key executives?
Avinger's management team includes the folowing people:
- Mr. Jeffrey M. Soinski, Pres, CEO & Director (Age 56)
- Mr. Matthew B. Ferguson, Chief Bus. Officer & CFO (Age 50)
- Dr. John Bush Simpson, Founder (Age 74)
- Mr. Keith Schaefer, Chief Operating Officer
- Mr. Himanshu N. Patel, Chief Technology Officer (Age 58)
When did Avinger IPO?
(AVGR) raised $60 million in an initial public offering (IPO) on Friday, January 30th 2015. The company issued 4,600,000 shares at $12.00-$14.00 per share. Canaccord Genuity and Cowen and Company served as the underwriters for the IPO and Oppenheimer, BTIG and Stephens were co-managers.
Has Avinger been receiving favorable news coverage?
Press coverage about AVGR stock has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. Avinger earned a daily sentiment score of 0.14 on Accern's scale. They also gave news headlines about the medical device company an impact score of 45.86 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.
How do I buy shares of Avinger?
Shares of AVGR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Avinger's stock price today?
One share of AVGR stock can currently be purchased for approximately $1.42.
How big of a company is Avinger?
Avinger has a market capitalization of $7.68 million and generates $9.93 million in revenue each year. The medical device company earns $-48,730,000.00 in net income (profit) each year or ($70.07) on an earnings per share basis. Avinger employs 65 workers across the globe.
How can I contact Avinger?
Avinger's mailing address is 400 CHESAPEAKE DRIVE, REDWOOD CITY CA, 94063. The medical device company can be reached via phone at 650-241-7900 or via email at [email protected]
MarketBeat Community Rating for Avinger (NASDAQ AVGR)
MarketBeat's community ratings are surveys of what our community members think about Avinger and other stocks. Vote "Outperform" if you believe AVGR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AVGR will underperform the S&P 500 over the long term. You may vote once every thirty days.
